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Edited by Ivan SadowskiAbstract The rat catalase gene carries a TATA-less promoter
and its transcriptional mechanism is interesting because of down-
regulation in liver injury. We characterized the core element in
the promoter and found that C/EBP-b binding downstream of
the transcription initiation site plays a crucial role for transcrip-
tion. The multiple complexes binding to the promoter were com-
posed of homodimers and heterodimers of C/EBP-b isoforms.
Transduction of the C/EBP-b gene showed complete reconstitu-
tion of multiple binding complexes in HeLa cells, similar to nor-
mal liver. Furthermore, C/EBP-b was observed to bind to the
endogenous catalase promoter. These data suggest that multiple
complex formation of C/EBP-b regulates transcription in the
TATA-less catalase promoter.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Transcriptional regulation1. Introduction
Catalase is an antioxidant enzyme, which catalyzes the
decomposition of hydrogen peroxide, and has a central role in
defense against oxidants generated through various metabolic
pathways, together with other enzymes such as superoxide dis-
mutase and glutathione peroxidase [1]. Catalase activity is
found in the liver at a high level, as well as in the kidney and
erythrocytes, but is scarce in connective tissue. We recently re-
ported that catalase gene expression was signiﬁcantly decreased
in acute liver injury induced by carbon tetrachloride [2] and in
hepatocarcinogenesis [3]. It is therefore of interest to elucidate
the mechanism of regulation in catalase gene expression.
The rat catalase gene is a single-copy gene with 13 exons
spanning 33 kb, and has multiple transcription initiation sites.
The promoter region of the gene was shown to have at least
eight CCAAT boxes and ﬁve GT boxes, but lacks a TATA
box and initiator consensus sequence [4]. Furthermore, we pre-
viously observed negative regulatory elements that suppress
catalase transcription in hepatoma cells [3,5]. Concerning the
catalase promoter, we showed that the region at 126 to
26 bp from the translation initiation codon shows minimal
promoter activity, and four protein complexes bind to this re-
gion [6].*Corresponding author. Fax: +81 859 34 8274.
E-mail address: kensato@grape.med.tottori-u.ac.jp (K. Sato).
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plexes containing RNA polymerase II are assembled on TFIID
binding to the TATA box. Accordingly, the TATA box, as
well as the CCAAT box [7], is an essential element for gene
expression. On the other hand, the TATA-less promoter often
has a pyrimidine-rich initiator element in the transcription ini-
tiation site [8]. The absence of both an initiator element and a
TATA box in the promoter region was reported to result in
multiple transcription initiation sites in the case of the mouse
thymidylate synthase gene [9]. Therefore, the aim of this study
was to elucidate the transcriptional mechanism and regulatory
factors in the rat catalase promoter.2. Materials and methods
2.1. Cell culture
The human hepatoma cell line HepG2, the human cervical carci-
noma cell line HeLa, and the rat hepatoma cell line Reuber were cul-
tured in Dulbeccos modiﬁed Eagles medium (DMEM) supplemented
with 10% fetal calf serum (FCS), 150 U/ml penicillin, and 100 lg/ml
streptomycin in a humidiﬁed atmosphere of 5% CO2.
2.2. Plasmid construction
CAT reporter plasmids of the rat catalase gene promoter were con-
structed based on the pUC0CAT vector, as described in previously [6].
A site-directed mutant (C/EBP-b mut) was generated by polymerase
chain reaction (PCR) using region I (126 to 26)-cloned plasmid
DNA as the template and a mismatched-primer, TCCGGCCCTCGG-
TACTCACGTTC in 53 to 31 bp. The expression vectors for the rat
C/EBP-a and C/EBP-b were constructed under the control of the cyto-
megalovirus promoter with fragments derived from cDNA clones. All
constructs were puriﬁed by CsCl equilibrium centrifugation.
2.3. Chloramphenicol acetyltransferase (CAT) assay
HepG2 cells and HeLa cells were inoculated in 60 mm dishes at
3.0 · 105 and 1.0 · 105 cells/dish, respectively, and were transfected
with a total of 10 lg of plasmids by the calcium phosphate precipita-
tion method [10]. Transfected HepG2 cells and HeLa cells were har-
vested 48 and 72 h after transfection, respectively. Cell extract was
prepared by sonication and centrifugation at 15000 · rpm for 5 min
at 4 C, and then treated with 65 C for 5 min to inactivate chloram-
phenicol deacetylase. The CAT activities were detected by separation
of acetylated chloramphenicol by high-performance liquid chromatog-
raphy [3]. In all cases, transfection data represent the average of ﬁve
independent experiments.
2.4. Nuclear extract preparation and electrophoretic mobility shift assay
(EMSA)
Nuclear extracts from the rat liver and cell lines were prepared as de-
scribed previously [2,11,12]. HeLa cells were transfected with expres-
sion vectors by the calcium phosphate-coprecipitation method [10],
and the nuclear extract was isolated 48 h after transfection. Probesation of European Biochemical Societies.
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EBP-b consensus binding site [13], and a C/EBP consensus element
were synthesized as double-stranded oligomers. These probes were
end-labeled with T4 polynucleotide kinase and [c-32P]-ATP. EMSAs
were performed by a previous method with slight modiﬁcation [12].
Brieﬂy, 1–4 lg of nuclear extract was preincubated for 30 min on ice
with 1 lg poly d(I-C) and 10 lg bovine serum albumin in 10 ll of bind-
ing buﬀer [25 mM HEPES-KOH, pH 7.9, 40 mM KCl, 0.1 mM
EDTA, 10 mM MgCl2, 5 lM ZnSO4, 5% b-mercaptoethanol,
0.5 mM phenylmethylsulfonyl ﬂuoride (PMSF), and 7.5% glycerol].
One fmol of the labeled probe (1 · 105 cpm) was added and incubated
for 30 min on ice, and then subjected to 5% polyacrylamide gel electro-
phoresis (PAGE) in TGE buﬀer (50 mM Tris, 380 mM glycine, and
2 mM EDTA, pH 8.2). For the competitive EMSA, 100-fold excess
of unlabeled DNA fragments were added to the binding reaction with
the labeled probe. For supershift experiments of EMSA, nuclear ex-
tracts were preincubated for 30 min on ice with 1 lg polyclonal anti-
C/EBP-b Antibody (C-19) (Santa Cruz Biotech, Santa Cruz, CA,
USA) prior to addition of the labeled probe.
2.5. Chromatin immunoprecipitation (ChIP) assay
The ChIP assay was performed according to the method of Karaya
et al. [14] with slight modiﬁcation. Reuber cells were treated with 1%
formaldehyde for 10 min followed by washing with PBS. The cell ly-
sates were disrupted by sonication, yielding chromatin fragments be-
tween 100 and 500 bp in size. Immunoprecipitation was performed
with 5 lg of anti-C/EBP-b antibody (C-19). Precipitated DNA was
analyzed by PCR using the following primers pairs: the rat catalase
promoter, forward, 5 0-TTCCAATCCTGTCCCTTCTA-30 and re-
verse, 5 0-TCCTTCCACTGCTTCATCT-3 0; the Igf-1 promoter, for-
ward, 5 0-GTCTGCTAACCCTGTCAGAAACAC-3 0 and reverse, 5 0-
GGCTCTATCTGCTCTGAATTTAGC-3 0.
2.6. Proteolytic clipping band shift assay
The proteolytic clipping band shift assay was conducted using stan-
dard EMSA conditions as described above by a previous method with
a slight modiﬁcation [15]. Brieﬂy, 1 ng to 10 lg trypsin 250 (DIFCO
Laboratories Inc, Detroit, MI, USA) in 10 mM Tris–HCl was addedFig. 1. Critical region for transcription on rat catalase promoter. (A) Relat
regions of the rat catalase gene in HepG2 cells. The transcription initiation
boxes, CCAAT boxes, and C/EBP-b binding element are schematically illust
expression vector (1.0 lg). CAT activity was normalized to b-galactosidase ac
activity generated by regions I + II CAT as 100%. Asterisks indicate statistic
region I of rat catalase promoter (+1 indicates the A in the ATG translatio
indicates a potential C/EBP-b binding site. Mutations of C/EBP-b binding el
lower cases.to the reaction mixture, and incubated on ice for 15 min. Two micro-
liter of trypsin inhibitor (Sigma) were then added to each reaction, and
subjected to 5% PAGE in TGE buﬀer.3. Results and discussion
3.1. Critical region for transcription on the rat catalase promoter
Previously, we have shown that the 126 to 26 bp region
from the translation initiation site had basic transcriptional
activity in the rat ﬁbroblast cell line 3Y1, and that four protein
complexes bind to this region in the normal rat liver [6]. To
conﬁrm the critical region for transcriptional regulation in
the rat catalase promoter, the CAT assay in HepG2 human
hepatoma cells was carried out using various promoter dele-
tion mutants of the gene (Fig. 1A). CAT plasmids carrying
the promoter regions, 187 to 26 bp, 164 to 26 bp, and
126 to 26 bp (regions I + II) were found to generate CAT
activity at a high level in HepG2 cells. CAT plasmid with trun-
cated promoter (72 to 26 bp; region I) also showed 57%
activity of the CAT plasmid with a 126 bp promoter (regions
I + II). These results suggested that the minimum segment (re-
gion I) holds basic promoter activity, although CCAAT box in
regain IV exhibited enhancer activity. The transcriptional
activities of these regions seemed to be correlated with a num-
ber of transcriptional initiation sites, namely six initiation sites
located in region II and a single site in region I determined by
primer extension assay [4].
To determine transcription factor(s) binding to the catalase
promoter minimum segment, the sequence 72 to 26 bp
was analyzed by the method of Quandt et al. [16]. The core se-
quence similar to the C/EBP-b consensus binding site, TT/ive CAT activities expressed by constructs carrying various promoter
sites are shown with hookshaped arrows at the top of the panel. GT
rated. Various CAT constructs (9.0 lg) were co-transfected with LacZ
tivity and relative CAT activities are presented in percent, based on the
al signiﬁcance vs. region I CAT (P < 0.01). (B) DNA sequences of the
n initiation codon of catalase gene) and C/EBP binding sites. Arrow
ement based on 53 to 31 bp of catalase promoter were indicated as
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opposite direction (Fig. 1B). Therefore, to elucidate the role
of the C/EBP-b binding site of the catalase promoter on tran-
scription activity, we carried out a CAT assay with the catalase
promoter mutated in the C/EBP-b binding sequence. As shown
in Fig. 1A, the region I promoter with a four nucleotide muta-
tion in the C/EBP-b sequence completely lost transcription
activity compared with the wild type promoter, suggesting that
the C/EBP-b binding site is essential for transcription in the rat
catalase TATA-less promoter. Surprisingly, the GC-box and
CCAAT-box located upstream of the initiation sites appear
to be unnecessary.
3.2. C/EBP-b binding site in the rat catalase promoter
We wanted to demonstrate that C/EBP-b binds to the cata-
lase promoter minimum segment. Thus, we performed EMSA
using the promoter region as a probe and various fragments
from region I and synthetic oligonucleotides as competitors.
As shown in Fig. 2A, four major complexes binding to region
I were observed in nuclear extracts derived from rat normal li-
ver (lane 3), and a similar pattern of binding complexes was
shown by the regions I + II probe (lane 2). This result indi-
cated that the catalase promoter was controlled by only the
CEBP-b enhancer element in region I. Therefore, to focus
the binding sequence, we performed competitive EMSA
probed by the region I DNA fragment. As shown in Fig. 2B,
the non-labeled DNA fragment from region I, which is used
as a competitor of EMSA, completely eliminated all of the
complex binding to the region I (lane 6). In contrast, DNA
fragments (74/53 and 58/37), which were truncated C/
EBP-b binding sequences, hardly competed with probe binding
(lanes 7 and 8). Moreover, the core sequence in the catalase
promoter (53/31) competed with the region I probe (lane
9); while the core sequence with mutation could not inhibit
the complex binding (lane 10). Likewise, C/EBP-b and C/Fig. 2. C/EBP-b binding element at 53 to 31 bp. (A) EMSA was performe
(P), labeled probe (regions I + II); lane 2, EMSA with regions I + II; lane 3
probes, 100-fold excess of unlabeled DNA fragments indicated in C were used
the results of competition.EBP consensus oligonucleotides competed against the region
I probe to bind all the complexes (lanes 11 and 12). These re-
sults are summarized in Fig. 2C, and suggested an important
role for the C/EBP-b element on complex binding to the cata-
lase promoter region.
3.3. Identiﬁcation of C/EBP-b binding to the catalase promoter
To identify the binding complexes on the catalase core pro-
moter, we determined heat-stability of these complexes, based
on the report that C/EBP-b is very stable to heat treatment
[17]. Nuclear extracts were treated with various diﬀerent tem-
peratures, and were used in EMSA. As expected, all the com-
plexes binding to region I were stable to heat treatment up to
100 C for 10 min (Fig. 3A, lane 8). This observation suggested
that C/EBP-b might bind to region I in the rat catalase pro-
moter.
Furthermore, to conﬁrm this assumption, we performed
EMSA with an antibody against C/EBP-b. Nuclear extract
pre-treated with anti-C/EBP-b antibody was decreased in most
of the binding complexes to the region I probe, except for the
smallest complex (Fig. 3B, lane 11). In this EMSA, a larger
super-shifted complex was not observed, and all the complexes
were not aﬀected by binding, because of speciﬁcity of the anti-
body used in this experiment. These results indicated that the
C/EBP-b was a core transcription factor in the complexes.
On the other hand, HeLa cells, the human cervical cancer
cell line, express less C/EBP subfamilies. Therefore, we trans-
duced the C/EBP-b expression vector transiently into the HeLa
cells, and determined the nuclear extract from the HeLa cells
by EMSA with the region I probe. In this experiment, the C/
EBP-b expression vector generated similar complexes to nor-
mal liver and Reuber, which is a well-diﬀerentiated rat hepa-
toma cell line. (Fig. 3C, lane 18). However, HeLa cells
transduced with the C/EBP-a expression vector only produced
a single large sized complex similar to the largest complex ind with DNA fragments isolated from the rat catalase promoter. Lane 1
, EMSA with region I. (B) Competitive EMSA. Region I was used as
as competitors. (C) Summary of competitive EMSA. + and  indicate
Fig. 3. Identiﬁcation of binding complexes on rat catalase promoter region I. (A) Heat-stability of binding complexes. Nuclear extract was treated at
indicated temperature for 5 and 10 min. NT shows untreated nuclear extract, and P exhibits probe without nuclear extract. (B) Supershift assay using
anti-C/EBP-b antibody: – means EMSA without no antibody (lane 10); Pre-immune shows EMSA with pre-immune rabbit IgG (lane 12). (C) EMSA
was performed with 4.0 lg of nuclear extract derived from HeLa cells transfected each expression vector. Extract from empty vector-infected cells
(Vector, lane 16) and C/EBP-a and C/EBP-b expression vector-infected cells (lanes 17 and 18) were used for EMSA. a + b indicates EMSA using
nuclear extract from cells transfected with both the expression vector (lane 19), and aNE + bNE shows mixed nuclear extracts from each expression
vector-transfected cells (lane 20). (D) Relative CAT activities by co-transfection of regions I + II CAT constructs and C/EBP-a and C/EBP-b
expression vector in HeLa cells. (E) Binding of C/EBP-b to the rat catalase promoter in vivo. Cross-linked chromatin isolated from Reuber cells were
immunoprecipitated with pre-immune rabbit IgG (lane 23), anti-C/EBP-b antibody (lane 24) and without antibody (lane 22). An aliquot of the total
chromatin DNA was used for input (lane 21). Precipitated DNA was subjected to PCR with a primer-pair speciﬁc to the rat catalase promoter that
ampliﬁed a 254 bp fragment (upper panel). As a positive control, PCR was carried out with a primer-pair speciﬁc to the rat Igf-1 promoter, which
ampliﬁed a 287 bp DNA fragment (lower panel).
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(lane 19) and mixed nuclear extract from C/EBP-a and -b
transduced HeLa cells (lane 20) were very similar to the com-
plexes in Reuber cells and normal liver. These results showed
that the multiple complexes were developed predominantly
by C/EBP-b isoforms, although the largest complex was de-
rived from C/EBP-a, and that quantitatively large amounts
of C/EBP-b were bound to the catalase promoter. Moreover,
a reporter assay with the catalase promoter revealed that these
expression vectors were able to activate transcription, and that
C/EBP-b played a critical role in catalase gene expression with
C/EBP-a in vitro (Fig. 3D).
Endogenous binding of the C/EBP-b to catalase gene pro-
moter was demonstrated by ChIP assay using Reuber cells,
which show a similar binding pattern as rat liver. Disruptedchromatin was precipitated with anti-C/EBP-b antibody, fol-
lowed by PCR with primers for the catalase promoter. As
shown in Fig. 3E, anti-C/EBP-b antibody enriched chromatin
containing the catalase promoter region (204/+50) (lane 4),
compared to chromatin precipitated by normal rabbit IgG or
without an antibody (lanes 2 and 3). The endogenous C/
EBP-b binding was conﬁrmed by ChIP assay of the insulin-like
growth factor-1 (Igf-1) gene, which is known to be a direct tar-
get of C/EBP-b [14,18]. These results indicated that C/EBP-b
bound to the endogenous catalase gene promoter.
3.4. Characterization of C/EBP-b binding
The C/EBP-b gene produces several molecular species of the
protein by alternative initiation of translation and by post-
translational modiﬁcation such as phosphorylation, in addi-
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erodimers within these molecules. In this study, the catalase
promoter was shown to bind to multiple complexes of C/
EBP-b. However, as shown in Fig. 4A, multiple complexes
were observed in EMSA probed by the region I fragment (lane
1). Interestingly, a diﬀuse single complex was seen when the
core sequence of the promoter and synthetic consensus se-
quences were used as probes (lanes 2–4). It is unknown
whether the molecular species from C/EBP-b were involved
in formation of all the complexes. To address this issue, we
carried out protease clipping and EMSA of nuclear extracts
from normal liver. Nuclear extract was treated with various
doses of trypsin for a few minutes, and applied to EMSA with
various probes. As shown in Fig. 4B, multiple complexes with
the region I probe (panel c) and single and large complexes by
consensus sequence or core sequence (panels a and b) were
converged on common, single and small binding complexes.
This observation indicates that the length of the probe could
determine formation of multiple complexes. Therefore, we pre-
pared various lengths of catalase promoters and synthetic oli-
gonucleotides with ﬂanking sequences, and performed EMSA
with these probes. As shown in Fig. 4C and D, regions I + II
(101 bp) and region I (47 bp) probes showed the same multiple
complex pattern (lanes 6 and 7), and probe 58/26 (32 bp)Fig. 4. Characterization of binding complexes on rat catalase promoter regio
and synthetic oligonucleotide for C/EBP-b consensus and C/EBP consensus
Nuclear extracts from normal liver were treated with trypsin at the concentra
C/EBP-b consensus and core sequences were used as probes. (C) EMSA usi
promoter DNA fragment (lanes 6 and 7). 58/26, 53/31 and C/EBP-
consensus was constructed by replacement of core sequence by C/EBP-b conalso showed a multiple complex pattern (lane 8). However,
the truncated probe 53/31 (23 bp), which contains the en-
tire C/EBP-b recognition sequence, formed a large and diﬀuse
single complex (lane 9). On the other hand, the synthetic
oligonucleotide for the C/EBP-b consensus sequence
(TCGCCTAGCATTTCATCACACGT; 23 bp) created a large
complex, but not multiple complexes (lane 10). Interestingly,
this C/EBP-b consensus sequence with the ﬂanking sequence
of region I (47 bp), which has no factor binding site, created
multiple complexes (lane 11). These multiple complexes were
also observed by the C/EBP-b consensus sequence with a
ﬂanking sequence from the multi cloning site of the pBSII vec-
tor (data not shown). These results suggested that multi com-
plexes of C/EBP-b bind to the longer probe, but not to the
short probe, because of their aﬃnity.
3.5. Conclusion
The rat catalase gene promoter lacks both a TATA box and
an initiator consensus element, culminating in multiple start
sites of transcription [4,7]. In this study, we showed that the
C/EBP-b binding element at 41 to 31 bp on the rat catalase
promoter was critical for transcription from multiple initiation
sites, and that C/EBP-b actually binds to this site. C/EBP-a
and C/EBP-b are highly expressed in the liver as liver-enrichedn I. (A) EMSA using region I fragment (lane 1), core element (lane 2),
sequences (lanes 3 and 4). (B) Proteolytic clipping band shift assay.
tion (1, 10, 102, 103, 104 ng/reaction), indicating by triangles. Region I,
ng various lengths of probes. Regions I and I + II were isolated from
b consensus were synthetic oligonucleotides (lanes 8–11), Region I/b
sensus sequence. These probes are shown in (D).
5790 M. Taniguchi et al. / FEBS Letters 579 (2005) 5785–5790transcription factors (LETFs) [19]. C/EBP-b is a member of
the bZIP family of transcription factors that binds to DNA
as homodimers or as heterodimers with other C/EBPs
[20,21]. On the rat catalase promoter, C/EBP-b might form
homodimers as well as heterodimers with C/EBP-a in liver.
Interestingly, these multiple complexes are formed immedi-
ately downstream of transcription initiation sites, and may
control transcription initiation by means of a novel mechanism
without interrupting transcription elongation. Formation of
multiple and ﬂexible complexes of C/EBP-b family polypep-
tides presumably might be involved in multiple transcription
start sites, although we have no evidence for the putative
mechanism of transcription initiation.Acknowledgments:We thank Mr. Koichi Adachi for his excellent tech-
nical assistance.References
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